glp 1 molecular structure GLP-1 receptor agonist 2 RCSB PDB - 3IOL: Crystal
Description
Ozempic (semaglutide) is a once-weekly GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus in adults
Puddu A, Sanguineti R, Montecucco F, Viviani GL
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have transformed diabetes and weight management, but emerging evidence links these medications to increased gallbladder complications
It helps with inflammatory pathways as do polyphenols
